Eric Fallon

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The production of therapeutic proteins by mammalian cell culture is complex and sets high requirements for process, facility, and equipment design, as well as rigorous regulatory and quality standards. One particular point of concern and significant risk to supply chain is the susceptibility to contamination such as bacteria, fungi, mycoplasma, and viruses.(More)
  • 1